Optimization of the balanced steady state free precession (bSSFP) pulse sequence for magnetic resonance imaging of the mouse prostate at 3T

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Mallett, Christiane L ^a,b   Foster, Paula J ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; ARTIFACT; BALANCED STEADY STATE FREE PRECESSION PLUSE SEQUENCE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; FLIP ANGLE; IMAGE DISPLAY; IMAGE QUALITY; IMAGING SYSTEM; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE CYCLING; PROCESS OPTIMIZATION; PROSTATE; PROSTATE RADIOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOGRAPHY; RADIOLOGICAL PARAMETERS; RECEIVER BANDWIDTH; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; WHOLE BODY MRI; ANIMAL; HISTOLOGY; IMAGE PROCESSING; LYMPH NODE; METHODOLOGY; NUDE MOUSE;

ANIMALS; ARTIFACTS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; PROSTATE;

EID: 79954476152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018361     Document Type: Article

References (35)

1. Canadian Cancer Society (2010) Canadian Cancer Statistics 2010.
2. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, et al. (1995) Prostate cancer in a transgenic mouse. Proc Nat Acad Sci USA 92: 3439-3443.
3. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, et al. (2000) LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44: 91-103.
4. Deeb D, Gao X, Jiang H, Dulchavsky SA, Gautam SC, (2009) Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR. Prostate 69: 851-860.
5. Wolf P, Alt K, Bühler P, Katzenwadel A, Wetterauer U, et al. (2008) Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice. Prostate 68: 129-138.
6. Bastide C, Bagnis C, Mannoni P, Hassoun J, Bladou F, (2002) A Nod Scid mouse model to study human prostate cancer. Prostate Cancer Prostatic Dis 5: 311-315.
7. Kozlowski JM, Fidler IJ, Campbell D, Xu Z, Kaighn ME, Hart IR, (1984) Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44: 3522-3529.
8. Stephenson RA, Dinney CPN, Gohji K, Ordonez NG, Killion JJ, Fidler IJ, (1992) Metastatic model for human prostate cancer using orthotopic implantation in nude mice. JNCI Journal of the National Cancer Institute 84: 951.
9. Jennbacken K, Gustavsson H, Tesan T, Horn M, Vallbo C, et al. (2009) The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone. Prostate 69: 1164-1175.
10. Adhami VM, Siddiqui IA, Sarfaraz S, Khwaja SI, Hafeez BB, et al. (2009) Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin Cancer Res 15: 1947-1953.
11. Degrassi A, Russo M, Scanziani E, Giusti A, Ceruti R, et al. (2007) Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials. Prostate 67: 396-404.
12. Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, et al. (1999) Early castration reduces prostatic carcinogenesis in transgenic mice. Urology 54: 1112-1119.
13. Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, et al. (2006) In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. Prostate 66: 708-717.
14. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H, (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A 98: 10350-10355.
15. Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, et al. (2004) Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 64: 3334-3343.
16. Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, et al. (1998) Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J Urol 160: 1500-1505.
17. Kumar AP, Bhaskaran S, Ganapathy M, Crosby K, Davis MD, et al. (2007) Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract. Clin Cancer Res 13: 2784-2794.
18. Nastiuk KL, Liu H, Hamamura M, Muftuler LT, Nalcioglu O, Krolewski JJ, (2007) In vivo MRI volumetric measurement of prostate regression and growth in mice. BMC Urol 7: 12.
19. Rad AM, Gao X, Deeb D, Gautam SC, Arbab AS, (2008) Imaging Mouse Prostate Gland by 3 Tesla Clinical MRI System. Open Magn Reson Rev 1: 60-63.
20. Song SK, Qu Z, Garabedian EM, Gordon JI, Milbrandt J, Ackerman JJ, (2002) Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res 62: 1555-1558.
21. Stoyanova R, Hachem P, Hensley H, Khor LY, Mu Z, et al. (2007) Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo. Int J Radiat Oncol Biol Phys 68: 1151-1160.
22. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730.
23. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, et al. (2003) Pten dose dictates cancer progression in the prostate. PLoS Biol 1: E59.
24. Kiss P, Eltoum IE, Suranyi P, Zeng H, Simor T, et al. (2009) Virtual in vivo biopsy map of early prostate neoplasm in TRAMP mice by MRI. Prostate 69: 449-458.
25. Stadler A, Schima W, Ba-Ssalamah A, Kettenbach J, Eisenhuber, (2007) Artifacts in body MR imaging: their appearance and how to eliminate them. Eur Radiol 17: 1242-1255.
26. Scheffler K, Lehnhardt S, (2003) Principles and applications of balanced SSFP techniques. Eur Radiol 13: 2409-2418.
27. Bernas LM, Foster PJ, Rutt BK, (2010) Imaging iron-loaded mouse glioma tumors with bSSFP at 3 T. Magnetic Resonance in Medicine 64: 23-31.
28. Miraux S, Massot P, Ribot EJ, Franconi JM, Thiaudiere E, (2008) 3D TrueFISP imaging of mouse brain at 4.7 T and 9.4 T. Journal of Magnetic Resonance Imaging 28: 497-503.
29. Bangerter NK, Hargreaves BA, Vasanawala SS, Pauly JM, Gold GE, Nishimura DG, (2004) Analysis of multiple-acquisition SSFP. Magn Reson Med 51: 1038-1047.
30. Foster-Gareau P, Heyn C, Alejski A, Rutt BK, (2003) Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magnetic Resonance in Medicine 49: 968-971.
31. Gonzalez-Lara LE, Xu X, Hofstetrova K, Pniak A, Brown A, Foster PJ, (2009) In Vivo Magnetic Resonance Imaging of Spinal Cord Injury in the Mouse. Journal of Neurotrauma 26: 753-762.
32. Heyn C, Bowen CV, Rutt BK, Foster PJ, (2005) Detection threshold of single SPIO-labeled cells with FIESTA. Magnetic Resonance in Medicine 53: 312-320.
33. Heyn C, Ronald JA, Mackenzie LT, MacDonald IC, Chambers AF, et al. (2006) In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magnetic Resonance in Medicine 55: 23-29.
34. Jirak D, Kriz J, Strzelecki M, Yang J, Hasilo C, et al. (2009) Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification. Magnetic Resonance Materials in Physics, Biology and Medicine 22: 257-265.
35. Ramadan SS, Heyn C, MacKenzie LT, Chambers AF, Rutt BK, Foster PJ, (2008) Ex-vivo cellular MRI with b-SSFP: quantitative benefits of 3 T over 1.5 T. Magnetic Resonance Materials in Physics, Biology and Medicine 21: 251-259.